<DOC>
	<DOCNO>NCT02173249</DOCNO>
	<brief_summary>The purpose study evaluate Plasma Pharmacokinetics Safety AC 170 0.24 % Healthy , Adult Subjects use twice daily one week .</brief_summary>
	<brief_title>A Single-Center , Open-Label , Study Plasma Pharmacokinetics Safety AC-170 0.24 %</brief_title>
	<detailed_description />
	<mesh_term>Cetirizine</mesh_term>
	<criteria>least 18 old 55 year age able selfadminister eye drop parent/legal guardian available purpose blood urine analysis within normal limit ocular health within normal limit know contraindication sensitivity study medication component active systemic ocular disorder ( refractive disorder ) inability comply control diet used prescription non prescription drug within washout period throughout study use alcohol tobacco within washout period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>